Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Other Operating Expenses (2017)

Bone Biologics (BBLG) has disclosed Other Operating Expenses for 2 consecutive years, with -$5262.0 as the latest value for Q4 2017.

  • On a quarterly basis, Other Operating Expenses changed N/A to -$5262.0 in Q4 2017 year-over-year; TTM through Dec 2017 was -$2.7 million, a 56171.04% decrease, with the full-year FY2017 number at -$2.7 million, down 56353.09% from a year prior.
  • Other Operating Expenses was -$5262.0 for Q4 2017 at Bone Biologics, down from $14113.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $784525.0 in Q1 2017 to a low of -$3.5 million in Q2 2017.